Bath & Body Works (NYSE:BBWI) Stock Gets Price Target Increase from UBS Group

Bath & Body Works (NYSE:BBWI) had its price target upped by equities research analysts at UBS Group from $17.00 to $22.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group‘s target price would indicate a potential upside of 3.02% from the stock’s previous close.

BBWI has been the topic of several other research reports. Barclays cut their price target on shares of Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Thursday, August 27th. Robert W. Baird reduced their price target on shares of Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating for the company in a research report on Thursday, August 27th. Citigroup upgraded shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price objective for the company in a research note on Tuesday, August 18th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a report on Tuesday, October 6th. Finally, BMO Capital Markets assumed coverage on shares of Bath & Body Works in a research report on Tuesday, September 8th. They set a “market perform” rating and a $20.00 target price for the company. Four equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $22.53.

Bath & Body Works Trading Up 1.3%

Shares of BBWI stock traded up $0.28 during mid-day trading on Friday, reaching $21.36. The stock had a trading volume of 3,937,759 shares, compared to its average volume of 5,905,448. The business’s fifty day moving average is $19.21 and its 200-day moving average is $19.82. The firm has a market cap of $4.31 billion, a price-to-earnings ratio of 5.56, a PEG ratio of 1.06 and a beta of 1.31. Bath & Body Works has a 1-year low of $14.27 and a 1-year high of $24.94.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The firm had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.50 billion. During the same period last year, the business posted $0.30 earnings per share. The company’s revenue for the quarter was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, analysts forecast that Bath & Body Works will post 2.74 earnings per share for the current year.

Institutional Investors Weigh In On Bath & Body Works

Hedge funds and other institutional investors have recently made changes to their positions in the company. Elevation Wealth Partners LLC lifted its stake in shares of Bath & Body Works by 5,278.8% in the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock valued at $41,000 after purchasing an additional 1,742 shares during the period. Parallel Advisors LLC grew its position in Bath & Body Works by 35.5% during the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock valued at $48,000 after buying an additional 673 shares during the period. United Southern Bank Trust Department acquired a new stake in Bath & Body Works during the third quarter valued at $58,000. Meeder Asset Management Inc. acquired a new stake in Bath & Body Works during the second quarter valued at $66,000. Finally, Global Retirement Partners LLC purchased a new position in Bath & Body Works in the second quarter valued at $71,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.